Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

News Conference News TCT 2023

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Todd Neale

October 26, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

Yael L. Maxwell

March 29, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Daily News

CMR Could Refine Early Management Decisions in Aortic Regurgitation

L.A. McKeown

July 27, 2022

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

News Daily News

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Michael O'Riordan

April 23, 2021

News Conference News STS 2020

Dedicated Structural Heart Training Pathway in the Works for Surgeons

Yael L. Maxwell

February 04, 2020

News Industry News

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

June 28, 2018

News Daily News

Ceiling-Suspended Shields Decrease Radiation Risk for TEE Operators During Structural Heart Procedures

Yael L. Maxwell

March 21, 2018

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Caitlin E. Cox

March 31, 2017

News Opinion Conversations in Cardiology

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

July 11, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Yael L. Maxwell

May 02, 2016

News Daily News

Un Estudio Avala que es Seguro Proceder a la UCI Post-TAVR en Pacientes Seleccionados

Todd Neale

April 27, 2016

News Daily News

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

October 01, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

Advertisement

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

ALIGN-AR: Positive Results for Trilogy Valve in Aortic Regurgitation

Women and Minorities Underrepresented in Heart Valve Trials

Radiation Exposure Highest for Interventional Imagers at Right Waist and Below

March 2023 News Roundup

CMR Could Refine Early Management Decisions in Aortic Regurgitation

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

New VARC-3 Definitions Provide a Road Map for Future Aortic Valve Research

Dedicated Structural Heart Training Pathway in the Works for Surgeons

Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR

Ceiling-Suspended Shields Decrease Radiation Risk for TEE Operators During Structural Heart Procedures

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Conversations in Cardiology: In the United States, Should TAVR Be Offered to a Low-Risk Patient?

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Un Estudio Avala que es Seguro Proceder a la UCI Post-TAVR en Pacientes Seleccionados

En los Albores de la TAVR, No Hubo Más Mortalidad en Pacientes tratados en Centros No Participantes en Ensayos

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content